Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 142280500 approvals

GC Medical Science Corporation

Official website

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

As of 2026-10-10, GC Medical Science Corporation has 494 Korean MFDS device approvals, 6 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

GC Medical Science Corporation was founded in 2003 and listed on KOSDAQ in 2014 as a medical device company operating diagnostic reagent, blood glucose, and hemodialysis solution businesses. In in-vitro diagnostics, the company supplies immunodiagnostic, biochemical, and molecular diagnostic reagents, distributes diagnostic reagents from Germany's DiaSys, and, building on the blood glucose and HbA1c measurement business acquired from Ceragem in 2015, offers blood glucose meters and HbA1c testing products, alongside hemodialysis solutions for chronic kidney failure patients. Based on 2025 consolidated revenue, segment mix was 54.1% diagnostic reagents, 31.1% hemodialysis solutions, 14.4% blood glucose, and 0.4% other, with an R&D workforce of 27, including 16 with master's or doctoral degrees.

Products & technology

  • Immunodiagnostic reagentsDisease diagnosis, prognosis, and treatment-related testing
  • Biochemical diagnostic reagentsDisease diagnosis, prognosis, and treatment-related testing
  • Molecular diagnostic reagentsDisease diagnosis, prognosis, and treatment-related testing
  • Blood glucose metersSelf blood glucose monitoring
  • HbA1c testing productsHbA1c (glycated hemoglobin) measurement
  • Hemodialysis solutionPerfusate for hemodialysis in chronic renal failure patients

Regulatory approvals

data.go.kr

6 Korean MFDS drug approvals · 2004–2026 / 494 Korean MFDS device approvals · 1971–2026

  • MFDS drugHD-Sol BCA2026-07-30
    Drug · Prescription · Approval202602206
  • MFDSClinical IVD strip for protein/lipid strip2026-06-02
    Product approval · Class 2체외 제인 26-4490 호
  • MFDSSphygmomanometer, electronic, automatic-inflation, non-portable2026-05-28
    Product approval · Class 2수인 26-4366 호
  • MFDSClinical chemistry automated analyser2026-05-22
    Product approval · Class 1체외 수신 26-1108 호
  • MFDSNebulizing system, ultrasonic2026-02-05
    Product approval · Class 2수인 26-4117 호
  • MFDSClinical chemistry automated analyser2025-12-16
    Product approval · Class 1체외 수신 25-2737 호
  • MFDSClinical chemistry automated analyser2025-11-19
    Product approval · Class 1체외 수신 25-2508 호
  • MFDSBlood glucose meter for self test2025-11-14
    Product approval · Class 3체외 제허 25-767 호
  • MFDSClinical chemistry automated analyser2025-10-27
    Product approval · Class 1체외 수신 25-2311 호
  • MFDSIVD strip for glucose self test2025-08-07
    Product approval · Class 3체외 제허 25-542 호
  • MFDSBlood glucose meter for self test2025-08-07
    Product approval · Class 3체외 제허 25-541 호
  • MFDSSphygmomanometer, electronic, automatic-inflation, non-portable2025-04-03
    Product approval · Class 2수인 25-4205 호
Show 68 more
  • MFDS drugHD B Powder(Sodium Bicarbonate)2025-03-11
    Drug · Prescription · Approval202500548
  • MFDSThermometer, electronic, infrared, ear2024-12-05
    Product approval · Class 2수인 24-659 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2024-11-12
    Product approval · Class 3체외 제허 24-779 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2024-07-12
    Product approval · Class 3체외 제허 24-474 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2024-07-12
    Product approval · Class 3체외 제허 24-473 호
  • MFDSIVD reagent for infectious disease, immunological method2024-05-09
    Product approval · Class 3체외 제허 24-321 호
  • MFDSBlood collection unit, non-needle2024-04-30
    Product approval · Class 1수신 24-772 호
  • MFDSIVD strip for protein/lipid self test2023-12-01
    Product approval · Class 2체외 제인 23-5314 호
  • MFDSIVD strip for protein/lipid self test2023-12-01
    Product approval · Class 2체외 제인 23-5313 호
  • MFDSIVD reagents for diabetes mellitus2023-11-28
    Product approval · Class 2체외 제인 23-5300 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2023-11-07
    Product approval · Class 3체외 제허 23-1041 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2023-10-12
    Product approval · Class 3체외 제허 23-978 호
  • MFDSSpectrophotometer for clinical use2023-10-06
    Product approval · Class 1체외 제신 23-1483 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2023-09-12
    Product approval · Class 3체외 제허 23-911 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2023-08-17
    Product approval · Class 3체외 제허 23-843 호
  • MFDSFlow type clinical chemistry automated analyzer2023-06-30
    Product approval · Class 1체외 수신 23-1597 호
  • MFDSThermometer, electronic, infrared, skin2022-12-23
    Product approval · Class 2수인 22-4603 호
  • MFDSThermometer, electronic, infrared, skin2022-12-23
    Product approval · Class 2수인 22-4601 호
  • MFDSThermometer, electronic, infrared, ear2022-10-27
    Product approval · Class 2수인 22-4504 호
  • MFDSThermometer, electronic, infrared, ear2022-10-27
    Product approval · Class 2수인 22-4503 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2022-09-26
    Product approval · Class 3체외 제허 22-643 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2022-03-23
    Product approval · Class 2체외 수인 22-4155 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2022-03-11
    Product approval · Class 2체외 수인 22-4133 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2022-03-04
    Product approval · Class 2체외 수인 22-4126 호
  • MFDSHematology analyzer, cell-quantifying2022-02-07
    Product approval · Class 1체외 수신 22-163 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-11-18
    Product approval · Class 3체외 제허 21-924 호
  • MFDSClinical chemistry automated analyser2021-10-18
    Product approval · Class 1체외 수신 21-1888 호
  • MFDSTool for specimens2021-10-06
    Product approval · Class 1수신 21-1835 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-07-29
    Product approval · Class 3체외 제허 21-649 호
  • MFDSSphygmomanometer, electronic, automatic-inflation, non-portable2021-07-23
    Product approval · Class 2수인 21-4360 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-06-25
    Product approval · Class 3체외 제허 21-526 호
  • MFDSIVD strip for protein/lipid self test2021-02-22
    Product approval · Class 2체외 제인 21-4141 호
  • MFDSBlood glucose meter for self test2021-01-20
    Product approval · Class 3체외 제허 21-47 호
  • MFDSIVD strip for glucose self test2021-01-18
    Product approval · Class 3체외 제허 21-40 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-10-28
    Product approval · Class 3체외 제허 20-916 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-08-28
    Product approval · Class 3체외 제허 20-756 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-08-03
    Product approval · Class 3체외 제허 20-616 호
  • MFDSFluorimetric immunoassay analyzer(FIA), stationary2020-08-03
    Product approval · Class 1체외 제신 20-1166 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-06-10
    Product approval · Class 3체외 제허 20-462 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-05-28
    Product approval · Class 3체외 제허 20-405 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-05-28
    Product approval · Class 3체외 제허 20-404 호
  • MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, immunological methodRevoked2020-04-28
    Product approval · Class 4체외 수허 20-89 호
  • MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, immunological methodRevoked2020-04-27
    Product approval · Class 4체외 수허 20-87 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-03-10
    Product approval · Class 3체외 제허 20-172 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2020-03-10
    Product approval · Class 2체외 수인 20-4143 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2020-03-10
    Product approval · Class 2체외 수인 20-4144 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2020-03-10
    Product approval · Class 2체외 수인 20-4145 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2020-03-06
    Product approval · Class 2체외 수인 20-4136 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2020-03-06
    Product approval · Class 2체외 수인 20-4137 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2020-02-27
    Product approval · Class 2체외 수인 20-4122 호
  • MFDSMicrobial susceptibility testing analyzerRevoked2020-02-20
    Product approval · Class 1체외 수신 20-426 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2020-02-17
    Product approval · Class 1체외 수신 20-400 호
  • MFDSIVD reagents for electrolyte testsRevoked2019-11-14
    Product approval · Class 2체외 수인 19-4767 호
  • MFDSIVD reagents for electrolyte testsRevoked2019-11-13
    Product approval · Class 2체외 수인 19-4764 호
  • MFDSClinical IVD strip for glucose strip2019-11-01
    Product approval · Class 2체외 제인 19-4891 호
  • MFDSIVD reagents for anemia testRevoked2019-09-23
    Product approval · Class 2체외 수인 19-4641 호
  • MFDSIVD reagents for tumor markerRevoked2019-09-18
    Product approval · Class 3체외 수허 19-303 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2019-09-18
    Product approval · Class 3체외 수허 19-302 호
  • MFDSIVD reagents for autoimmune diseaseRevoked2019-09-18
    Product approval · Class 2체외 수인 19-4629 호
  • MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2019-09-17
    Product approval · Class 2체외 수인 19-4625 호
  • MFDSIVD reagents for allergy testRevoked2019-09-17
    Product approval · Class 2체외 수인 19-4626 호
  • MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2019-09-16
    Product approval · Class 2체외 수인 19-4620 호
  • MFDSIVD reagents for diabetes mellitusRevoked2019-09-16
    Product approval · Class 2체외 수인 19-4621 호
  • MFDSIVD reagents for diabetes mellitusRevoked2019-09-11
    Product approval · Class 2체외 수인 19-4616 호
  • MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2019-09-11
    Product approval · Class 2체외 수인 19-4617 호
  • MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2019-09-09
    Product approval · Class 2체외 수인 19-4610 호
  • MFDSIVD reagents for tumor markerRevoked2019-09-05
    Product approval · Class 3체외 수허 19-297 호
  • MFDSIVD reagents for tumor markerRevoked2019-09-05
    Product approval · Class 3체외 수허 19-296 호

Showing the 80 most recent of 500 records.

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched
Show 5 more patents

AI reads

MAA server logs · IP-verified
203
Times AI engines pulled GC Medical Science Corporation's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

202
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

8
live 0
Last 7 days
165
live 1
Last 30 days
203
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot159
  • GoogleGoogleOther30
  • PerplexityPerplexityBot10
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for GC Medical Science Corporation and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

SD BIOSENSOR INC.41 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Boditech Med Inc.36 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

DONG-A ST CO.,LTD34 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

OSANG HEALTHCARE CO.,LTD.31 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

Sugentech, Inc.24 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

NanoenTek,Inc.23 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

HUMASIS CO., LTD.22 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

Access Bio, Inc.21 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

Precision Biosensor Inc.18 shared

KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.

PCL. Inc18 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

i-SENS, Inc.17 shared

Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.

RollingStone Co., Ltd.16 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition